Clinical microbiological case: A Nicaraguan woman with skin lesions on the left elbow and foot

Clinical Microbiology and Infection

Volumn 7, Issue 2, 2001, Pages 84-87

  Garcia Lechuz Moya J M ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; PENICILLIN G; STREPTOCOCCUS ANTIGEN;

AGED; ANTIGEN DETECTION; ARM AMPUTATION; ARTHROCENTESIS; ARTICLE; BLOOD CULTURE; CASE REPORT; DEBRIDEMENT; ELBOW DISEASE; ELBOW RADIOGRAPHY; FEMALE; FEVER; FOOT DISEASE; GRAM POSITIVE BACTERIUM; GRAM STAINING; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; LUMBAR PUNCTURE; MALAISE; MICROBIOLOGICAL EXAMINATION; NICARAGUA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SKIN DEFECT; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 0035262132     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2001.00109.x     Document Type: Article

References (31)

1. Infecciones invasoras causadas por Streptococcus β-hemolítico del gupo A
2. Septic shock induced by group A streptococcal infections: Clinical and therapeutic aspects
3. Invasive group A Streptococcus infections
4. Necrotising fasciitis
5. Effect of antibiotics on toxin production and viability of Clostridium perfringens
6. Hemolytic streptococcus gangrene
7. Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition
8. Infecciones necrosantes de partes blandas. A propósito de 40 casos
9. Epidemiology and etiopathogeny of necrotizing fascitis and streptococcal shock syndrome
10. Zur Kenntnis und behandlung des nekrotisiereden Erysipels
11. Streptococo β-hemolítico grupo A
12. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin
13. Streptococcal infections of skin and soft tissues
14. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production
15. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome
16. Outbreak of group A streptococcus septicemia in children: Clinical, epidemiologic and microbiological correlates
17. A comparison of Streptococcus pyogenes (group A streptococcal) bacteremia at an urban and a suburban hospital. The importance of intravenous drug use
18. Cytokine production by human mononuclear cells in response to streptococcal exotoxins
19. Streptococcal toxic shock syndrome; synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O
20. Temporal relationship of cytokine release by peripheral blood mononuclear cells stimulated by the streptococcal superantigen pep M5
21. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C
22. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF)
23. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A
24. Antigen detection in the rapid diagnosis of severe extrapharyngeal infections caused by group A streptococcus
25. Streptococcal toxic-shock syndrome: Spectrum of disease, pathogenesis and new concepts in treatment
26. Streptococcal toxic shock-like syndrome. The importance of surgical intervention
27. Experimental approach to the problem of treatment failure with penicillin group A streptococcal infection in mice
28. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin
29. The Eagle effect revisited: Efficacy of clindamycin, erythromycin and penicillin in the treatment of streptococcal myositis
30. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: An explanation for the inoculum effect
31. Intravenous inmunoglobulin therapy for toxic shock syndrome